Twitter | Search | |
Search Refresh
Blood Journal May 16
Reply Retweet Like
Nagi El Saghir MD 11m
Congratulations to our 2 Excellent Nour Moukalled & Haidar Al Darsa Rising Stars
Reply Retweet Like
Madeleine Verhovsek, MD 2h
So many things that keep us up at night as Hematologists!
Reply Retweet Like
DrFeelGood 35m
☀ Hiring: /Oncology, HEMATOLOGY/ONCOLOGY PHYSICIAN / TEXAS ☑ Apply Now ☞
Reply Retweet Like
Aptitude Health May 17
CAR T-cell development against T-cell malignancies is challenging due to the similarities between the therapeutic, normal, and malignant T-cells. Our event provides the practical CAR-T insights you need.
Reply Retweet Like
DrFeelGood 6h
☀ Hiring: Oncology opening in Michigan ☑ Apply Now ☞ https://174.129.45.87/?p=349656
Reply Retweet Like
EMJ Hematology May 24
Why not like us on to make sure you're in the know about the latest !
Reply Retweet Like
Hasan Faheema 19h
Schmitz et al have developed and validated a risk score for CNS relapse—the Central Nervous System International Prognostic Index —in DLBCL Two-year risk of CNS relapse was < 5% in the low- and intermediate-risk groups and ≥ 10% in the high-risk group.
Reply Retweet Like
Pulsus Conferences 24h
World’s leading international conference on hematology and oncology. Join us to explore something more in hematology/ oncology with experts in field, this July at Rome, Italy. Get to know more at:
Reply Retweet Like
OpenCME Hematology 24h
New CME: Experts offer insights and best practices for nurses treating pts with B-cell malignancies with oral agents
Reply Retweet Like
VladK 9h
Reply Retweet Like
Aptitude Health May 23
CAR-T therapies are the latest, perhaps most promising, treatment breakthrough in . Production and market access is a challenge. Our event provides the practical CAR-T insights tailored to the US market.
Reply Retweet Like
Wayne H. Liang, MD MS May 16
Reply Retweet Like
DynaMed Plus May 21
Approach to erythrocytosis in adults has just been updated in DynaMed Plus:
Reply Retweet Like
knowmedge May 19
Time for an edition of the
Reply Retweet Like
Vijaya L May 23
We provide a stimulating scientific environment and a platform to exchange ideas, establish research collaboration and networking. Join us this July at Rome, Italy. Explore more at:
Reply Retweet Like
DrFeelGood May 24
☀ Hiring: /Oncology Locums Physician Needed in NV! (GS) ☑ Apply Now ☞
Reply Retweet Like
ɑӀíՏմӀԵɑղ👨🏻‍⚕️💉 May 18
In our lab. A 17-year-old man with chronic myeloid leukemia #
Reply Retweet Like
Shikha Jain MD, FACP May 16
Reply Retweet Like
BPDCNinfo 21h
At the intersection of , , , and , there’s a lot to consider when diagnosing BPDCN. But knowing can be as simple as CD123. Find out why this cell surface marker is a key to identifying this elusive disease:
Reply Retweet Like